MOG and myeloid sarcoma: The growing awareness of MOGAD in recent years has elevated MOG antibody testing to a critical diagnostic tool, essential for differentiating between MS, NMO, and MOGAD, particularly in patients presenting with abnormal neurology and radiology including optic neuritis and myelitis.